 Joanne Masterson
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 21 | 2024 | 296 | 5.830 |
Why?
| | Eosinophils | 17 | 2021 | 278 | 3.340 |
Why?
| | Eosinophilia | 9 | 2021 | 186 | 2.800 |
Why?
| | Claudins | 3 | 2024 | 24 | 2.120 |
Why?
| | Epithelial Cells | 11 | 2024 | 950 | 1.940 |
Why?
| | Enteritis | 4 | 2022 | 82 | 1.920 |
Why?
| | Tight Junctions | 4 | 2024 | 68 | 1.520 |
Why?
| | Gastroesophageal Reflux | 5 | 2023 | 234 | 1.480 |
Why?
| | MicroRNAs | 4 | 2024 | 600 | 1.330 |
Why?
| | Esophagus | 10 | 2019 | 225 | 1.280 |
Why?
| | Gastritis | 3 | 2021 | 84 | 1.150 |
Why?
| | Esophagitis | 2 | 2018 | 65 | 1.120 |
Why?
| | Claudin-1 | 2 | 2019 | 21 | 0.790 |
Why?
| | Colitis | 6 | 2017 | 223 | 0.770 |
Why?
| | Barrett Esophagus | 1 | 2023 | 147 | 0.730 |
Why?
| | Esophageal Mucosa | 2 | 2019 | 17 | 0.730 |
Why?
| | Intestines | 2 | 2021 | 326 | 0.700 |
Why?
| | Ileitis | 4 | 2015 | 26 | 0.680 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 273 | 0.680 |
Why?
| | Eosinophil Peroxidase | 2 | 2018 | 6 | 0.660 |
Why?
| | Gastrointestinal Diseases | 2 | 2019 | 182 | 0.650 |
Why?
| | Ileum | 2 | 2015 | 90 | 0.610 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 249 | 0.580 |
Why?
| | Receptors, CCR3 | 2 | 2018 | 8 | 0.540 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2017 | 153 | 0.540 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 140 | 0.530 |
Why?
| | Anti-Inflammatory Agents | 3 | 2014 | 447 | 0.530 |
Why?
| | Crohn Disease | 4 | 2015 | 196 | 0.520 |
Why?
| | Fibrosis | 2 | 2015 | 453 | 0.510 |
Why?
| | Inflammation | 7 | 2024 | 2477 | 0.510 |
Why?
| | Interleukin-33 | 1 | 2015 | 38 | 0.500 |
Why?
| | Vascular Remodeling | 1 | 2017 | 153 | 0.500 |
Why?
| | Intestinal Mucosa | 7 | 2016 | 532 | 0.490 |
Why?
| | Epithelium | 5 | 2019 | 295 | 0.470 |
Why?
| | Disease Models, Animal | 8 | 2017 | 3531 | 0.450 |
Why?
| | Signal Transduction | 7 | 2019 | 4509 | 0.450 |
Why?
| | Mice, Transgenic | 4 | 2019 | 1947 | 0.440 |
Why?
| | Interleukin-5 | 1 | 2012 | 30 | 0.420 |
Why?
| | Acute Lung Injury | 2 | 2017 | 298 | 0.400 |
Why?
| | Celiac Disease | 1 | 2015 | 264 | 0.390 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2010 | 34 | 0.380 |
Why?
| | Leukocyte Count | 3 | 2021 | 293 | 0.370 |
Why?
| | Asthma | 2 | 2021 | 2029 | 0.360 |
Why?
| | Humans | 41 | 2024 | 114623 | 0.350 |
Why?
| | Cadherins | 3 | 2010 | 175 | 0.350 |
Why?
| | Mice | 17 | 2023 | 14860 | 0.340 |
Why?
| | Regeneration | 1 | 2010 | 160 | 0.320 |
Why?
| | Animals | 22 | 2023 | 31694 | 0.310 |
Why?
| | Lung | 4 | 2018 | 3558 | 0.310 |
Why?
| | Child | 18 | 2021 | 18404 | 0.300 |
Why?
| | Cell Line, Transformed | 2 | 2019 | 133 | 0.300 |
Why?
| | Bromodeoxyuridine | 1 | 2007 | 72 | 0.290 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 57 | 0.290 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2007 | 81 | 0.280 |
Why?
| | DNA, Neoplasm | 1 | 2007 | 157 | 0.280 |
Why?
| | Proton Pump Inhibitors | 3 | 2018 | 96 | 0.280 |
Why?
| | DNA Damage | 1 | 2007 | 351 | 0.250 |
Why?
| | Child, Preschool | 9 | 2019 | 9108 | 0.240 |
Why?
| | Cell Cycle | 1 | 2007 | 542 | 0.240 |
Why?
| | Protein Processing, Post-Translational | 1 | 2007 | 399 | 0.230 |
Why?
| | Receptors, CCR7 | 2 | 2015 | 24 | 0.220 |
Why?
| | Male | 18 | 2021 | 55554 | 0.220 |
Why?
| | Hypercapnia | 1 | 2023 | 51 | 0.210 |
Why?
| | Adolescent | 13 | 2019 | 17831 | 0.210 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 9 | 0.210 |
Why?
| | Mucosal-Associated Invariant T Cells | 1 | 2022 | 16 | 0.210 |
Why?
| | Th1 Cells | 2 | 2015 | 123 | 0.200 |
Why?
| | Female | 19 | 2021 | 59466 | 0.200 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2016 | 132 | 0.200 |
Why?
| | Dexamethasone | 3 | 2012 | 317 | 0.190 |
Why?
| | Disease Progression | 3 | 2023 | 2380 | 0.190 |
Why?
| | Immunoglobulin G | 2 | 2018 | 770 | 0.190 |
Why?
| | Biopsy | 4 | 2019 | 1036 | 0.180 |
Why?
| | Mice, Inbred C57BL | 6 | 2017 | 4689 | 0.180 |
Why?
| | Nanoparticles | 3 | 2018 | 313 | 0.170 |
Why?
| | GATA3 Transcription Factor | 2 | 2018 | 24 | 0.170 |
Why?
| | Antibodies, Monoclonal | 3 | 2017 | 1262 | 0.170 |
Why?
| | Homeostasis | 2 | 2021 | 573 | 0.170 |
Why?
| | Hypersensitivity | 3 | 2018 | 252 | 0.170 |
Why?
| | Cytokines | 4 | 2016 | 1840 | 0.160 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 250 | 0.160 |
Why?
| | Protein Stability | 1 | 2019 | 157 | 0.160 |
Why?
| | Phenotype | 3 | 2022 | 2796 | 0.160 |
Why?
| | Microbiota | 2 | 2016 | 647 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2023 | 3003 | 0.150 |
Why?
| | Colonic Diseases | 1 | 2018 | 25 | 0.150 |
Why?
| | Cell Movement | 5 | 2018 | 868 | 0.150 |
Why?
| | Respiratory Hypersensitivity | 1 | 2018 | 60 | 0.150 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2012 | 923 | 0.150 |
Why?
| | Hypoxia | 1 | 2024 | 957 | 0.150 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2319 | 0.140 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2017 | 6 | 0.140 |
Why?
| | Real-Time Polymerase Chain Reaction | 3 | 2012 | 313 | 0.140 |
Why?
| | Mucous Membrane | 3 | 2013 | 108 | 0.140 |
Why?
| | Electric Impedance | 1 | 2017 | 100 | 0.140 |
Why?
| | Chemokine CCL24 | 2 | 2019 | 9 | 0.140 |
Why?
| | Antibodies | 2 | 2017 | 371 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 169 | 0.140 |
Why?
| | Gene Expression | 2 | 2023 | 1421 | 0.130 |
Why?
| | Colon | 1 | 2018 | 233 | 0.130 |
Why?
| | Smad Proteins | 1 | 2016 | 39 | 0.130 |
Why?
| | Probiotics | 1 | 2016 | 46 | 0.130 |
Why?
| | Myeloid Cells | 1 | 2017 | 126 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 144 | 0.130 |
Why?
| | G(M1) Ganglioside | 1 | 2015 | 6 | 0.130 |
Why?
| | Inflammasomes | 1 | 2017 | 115 | 0.130 |
Why?
| | RNA, Ribosomal, 16S | 2 | 2015 | 485 | 0.130 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 913 | 0.130 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 535 | 0.120 |
Why?
| | Peroxidase | 1 | 2015 | 163 | 0.120 |
Why?
| | Neutrophils | 2 | 2017 | 1176 | 0.120 |
Why?
| | Receptor, Adenosine A2B | 1 | 2015 | 32 | 0.120 |
Why?
| | Fibronectins | 1 | 2015 | 108 | 0.120 |
Why?
| | Cell Culture Techniques | 1 | 2017 | 342 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 594 | 0.120 |
Why?
| | Interleukin-13 | 1 | 2015 | 122 | 0.120 |
Why?
| | Desmosomes | 1 | 2014 | 20 | 0.120 |
Why?
| | Constriction, Pathologic | 1 | 2015 | 208 | 0.120 |
Why?
| | Mice, Inbred C3H | 2 | 2016 | 239 | 0.120 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2015 | 68 | 0.120 |
Why?
| | Th17 Cells | 1 | 2015 | 58 | 0.120 |
Why?
| | Bronchi | 1 | 2016 | 231 | 0.120 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 168 | 0.120 |
Why?
| | Permeability | 2 | 2011 | 149 | 0.120 |
Why?
| | Chemokines | 1 | 2015 | 216 | 0.120 |
Why?
| | Th2 Cells | 2 | 2018 | 154 | 0.120 |
Why?
| | Trachea | 1 | 2016 | 224 | 0.120 |
Why?
| | Adult | 8 | 2021 | 30528 | 0.120 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2017 | 284 | 0.110 |
Why?
| | RNA, Bacterial | 1 | 2015 | 174 | 0.110 |
Why?
| | Autophagy | 1 | 2016 | 233 | 0.110 |
Why?
| | Biomarkers | 5 | 2019 | 3408 | 0.110 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.110 |
Why?
| | Neoplasms | 1 | 2007 | 2097 | 0.110 |
Why?
| | beta-Defensins | 1 | 2013 | 18 | 0.110 |
Why?
| | Oxazolone | 1 | 2012 | 5 | 0.110 |
Why?
| | Peptides | 1 | 2018 | 848 | 0.110 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 26 | 0.110 |
Why?
| | Killer Cells, Natural | 1 | 2015 | 380 | 0.100 |
Why?
| | Inflammation Mediators | 1 | 2015 | 477 | 0.100 |
Why?
| | Mucositis | 1 | 2012 | 18 | 0.100 |
Why?
| | Ischemia | 1 | 2015 | 362 | 0.100 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2015 | 339 | 0.100 |
Why?
| | Chemokine CCL19 | 1 | 2012 | 6 | 0.100 |
Why?
| | Chemokine CCL21 | 1 | 2012 | 13 | 0.100 |
Why?
| | Pregnenediones | 1 | 2012 | 21 | 0.100 |
Why?
| | Herpesvirus 4, Human | 1 | 2012 | 125 | 0.100 |
Why?
| | Kidney Diseases | 1 | 2015 | 350 | 0.100 |
Why?
| | Cells, Cultured | 2 | 2017 | 3881 | 0.100 |
Why?
| | Choristoma | 1 | 2012 | 23 | 0.100 |
Why?
| | Chemokine CCL11 | 1 | 2011 | 22 | 0.100 |
Why?
| | Anti-Allergic Agents | 1 | 2012 | 41 | 0.100 |
Why?
| | Fibroblasts | 1 | 2016 | 837 | 0.100 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 71 | 0.090 |
Why?
| | Neutrophil Infiltration | 1 | 2011 | 96 | 0.090 |
Why?
| | Smad Proteins, Receptor-Regulated | 1 | 2010 | 2 | 0.090 |
Why?
| | Mice, Inbred Strains | 1 | 2011 | 396 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 167 | 0.090 |
Why?
| | Naphthalenes | 1 | 2010 | 38 | 0.090 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2010 | 146 | 0.090 |
Why?
| | Infant | 3 | 2018 | 7959 | 0.080 |
Why?
| | Up-Regulation | 1 | 2012 | 807 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2012 | 383 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 282 | 0.080 |
Why?
| | Kidney | 1 | 2015 | 1188 | 0.080 |
Why?
| | Flow Cytometry | 4 | 2015 | 1083 | 0.080 |
Why?
| | beta-Galactosidase | 1 | 2007 | 62 | 0.070 |
Why?
| | Retrospective Studies | 4 | 2018 | 12542 | 0.070 |
Why?
| | Monocytes | 2 | 2023 | 502 | 0.070 |
Why?
| | Interleukin-1 | 1 | 2011 | 966 | 0.070 |
Why?
| | Mesoderm | 1 | 2008 | 138 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1342 | 0.070 |
Why?
| | Matrix Metalloproteinases | 1 | 2007 | 89 | 0.070 |
Why?
| | Chronic Disease | 1 | 2011 | 1578 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2017 | 2565 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 1 | 2010 | 2218 | 0.060 |
Why?
| | Dextran Sulfate | 2 | 2017 | 70 | 0.060 |
Why?
| | Cell Cycle Proteins | 1 | 2007 | 551 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2008 | 2186 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2279 | 0.060 |
Why?
| | Genes, Mitochondrial | 1 | 2023 | 12 | 0.050 |
Why?
| | Cell Line | 3 | 2018 | 2635 | 0.050 |
Why?
| | Esophagoscopy | 2 | 2016 | 184 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 2 | 2015 | 397 | 0.050 |
Why?
| | Rats | 1 | 2010 | 4958 | 0.050 |
Why?
| | Interleukin-1beta | 2 | 2017 | 370 | 0.050 |
Why?
| | Carbon Dioxide | 1 | 2023 | 218 | 0.050 |
Why?
| | Cell Line, Tumor | 1 | 2007 | 2710 | 0.050 |
Why?
| | International Cooperation | 1 | 2021 | 171 | 0.040 |
Why?
| | Mice, Mutant Strains | 2 | 2012 | 271 | 0.040 |
Why?
| | Acute Disease | 2 | 2015 | 910 | 0.040 |
Why?
| | Cell Differentiation | 1 | 2007 | 1700 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 381 | 0.040 |
Why?
| | Chemokine CCL26 | 1 | 2019 | 7 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2023 | 821 | 0.040 |
Why?
| | Middle Aged | 4 | 2021 | 26719 | 0.040 |
Why?
| | Endoscopy, Digestive System | 1 | 2019 | 110 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 2013 | 1691 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2015 | 1139 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 23 | 0.040 |
Why?
| | GTP-Binding Proteins | 1 | 2018 | 139 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.040 |
Why?
| | Receptors, CCR2 | 1 | 2017 | 28 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2018 | 2552 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2019 | 739 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 299 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2017 | 171 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 473 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 10455 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 279 | 0.030 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2016 | 57 | 0.030 |
Why?
| | Chloroquine | 1 | 2016 | 52 | 0.030 |
Why?
| | Macaca mulatta | 1 | 2016 | 131 | 0.030 |
Why?
| | Immunity, Mucosal | 1 | 2016 | 84 | 0.030 |
Why?
| | Respiratory System | 1 | 2016 | 137 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2017 | 316 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2015 | 119 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2177 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2015 | 128 | 0.030 |
Why?
| | Allergens | 1 | 2018 | 413 | 0.030 |
Why?
| | Keratinocytes | 1 | 2016 | 216 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2015 | 195 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2014 | 135 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2015 | 345 | 0.030 |
Why?
| | Models, Animal | 1 | 2016 | 344 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2015 | 102 | 0.030 |
Why?
| | Isoenzymes | 1 | 2015 | 283 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 555 | 0.030 |
Why?
| | Base Sequence | 1 | 2017 | 2114 | 0.030 |
Why?
| | Transcriptional Activation | 1 | 2015 | 337 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1143 | 0.030 |
Why?
| | Protein Binding | 1 | 2018 | 1889 | 0.030 |
Why?
| | Expressed Sequence Tags | 1 | 2012 | 38 | 0.030 |
Why?
| | Eosinophil Granule Proteins | 1 | 2012 | 20 | 0.030 |
Why?
| | Lysophospholipase | 1 | 2012 | 10 | 0.030 |
Why?
| | Antigens, CD | 1 | 2015 | 442 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1147 | 0.030 |
Why?
| | Carboxylic Ester Hydrolases | 1 | 2012 | 15 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 439 | 0.020 |
Why?
| | Pneumonia | 1 | 2017 | 567 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2012 | 157 | 0.020 |
Why?
| | Diet Therapy | 1 | 2012 | 36 | 0.020 |
Why?
| | Vimentin | 1 | 2012 | 58 | 0.020 |
Why?
| | Genome, Bacterial | 1 | 2012 | 106 | 0.020 |
Why?
| | Netrin-1 | 1 | 2011 | 11 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 435 | 0.020 |
Why?
| | Lymphoid Tissue | 1 | 2012 | 62 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 130 | 0.020 |
Why?
| | Keratins | 1 | 2012 | 176 | 0.020 |
Why?
| | Metagenome | 1 | 2012 | 122 | 0.020 |
Why?
| | Remission Induction | 1 | 2012 | 233 | 0.020 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2011 | 29 | 0.020 |
Why?
| | Gastric Mucosa | 1 | 2011 | 46 | 0.020 |
Why?
| | Specimen Handling | 1 | 2012 | 155 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2015 | 1131 | 0.020 |
Why?
| | Glycoproteins | 1 | 2012 | 304 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 508 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2353 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2012 | 620 | 0.020 |
Why?
| | Endoscopy | 1 | 2012 | 246 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 501 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2016 | 1076 | 0.020 |
Why?
| | Models, Genetic | 1 | 2012 | 562 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2012 | 723 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 797 | 0.020 |
Why?
| | Transforming Growth Factor beta | 1 | 2012 | 448 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2012 | 497 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1226 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6217 | 0.020 |
Why?
| | Immunologic Memory | 1 | 2010 | 313 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1629 | 0.020 |
Why?
| | Cytoskeleton | 1 | 2008 | 176 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 396 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2013 | 2762 | 0.020 |
Why?
| | Cell Survival | 1 | 2008 | 1020 | 0.010 |
Why?
| | Aged | 1 | 2021 | 19061 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1620 | 0.010 |
Why?
|
|
Masterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|